PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page

FDA Approves Xofluza, First New Treatment for Influenza in Nearly 20 Years.

by PEPID Newsroom | Oct 31, 2018 | Alerts

Yesterday the U.S. Food and Drug Administration approved Xofluza (balorxavir marhboxil), a new influenza treatment for acute uncomplicated influenza in people age 12 and older who have been symptomatic for no more than 2 days. This new drug, developed by Genentech,...

Recent Posts

  • Men’s Health Month – Closing Gaps in Prevention and Early Detection
  • Beyond the Beach – Occupational Skin Cancer Risks in Outdoor Workers
  • Tackling Antimicrobial Resistance: How to fight back against the rise in tough cases
  • The ‘Forever Chemicals’ Crisis: What Healthcare Providers Need to Know About PFAS
  • Top Challenges Faced by Emergency Medicine Residents and How to Overcome Them

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved